Key Details
Price
$1.00Annual ROE
99.93%Beta
-4688.11Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Nov 11, 2021Recent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Oct 17, 2022Analyst ratings
Recent major analysts updates
Jan 3, 22 Needham
BuyJan 3, 22 China Renaissance
BuyNov 19, 21 JP Morgan
OverweightMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Missfresh Limited doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
Disc Medicine Presents Positive Updated Results from Phase 1b Trial in Patients with Myelofibrosis (MF) and Anemia in an Oral Presentation at the 66th American Society of Hematology (ASH) Annual Meeting
MF
globenewswire.comDecember 8, 2024
WATERTOWN, Mass., Dec. 08, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today presented positive updated results from a Phase 1b trial of DISC-0974 in patients with myelofibrosis (MF) and anemia. The data, presented in an oral session at the 2024 American Society of Hematology (ASH) annual meeting in San Diego, CA, demonstrated that treatment with DISC-0974 results in substantial reductions in hepcidin and increases in iron levels translating to positive impact on clinically meaningful measures of anemia across a broad range of patient types.
FAQ
- What is the ticker symbol for Missfresh Limited?
- Does Missfresh Limited pay dividends?
- What sector is Missfresh Limited in?
- What industry is Missfresh Limited in?
- What country is Missfresh Limited based in?
- When did Missfresh Limited go public?
- Is Missfresh Limited in the S&P 500?
- Is Missfresh Limited in the NASDAQ 100?
- Is Missfresh Limited in the Dow Jones?
- When was Missfresh Limited's last earnings report?
- When does Missfresh Limited report earnings?
What is the ticker symbol for Missfresh Limited?
The ticker symbol for Missfresh Limited is NASDAQ:MF
Does Missfresh Limited pay dividends?
No, Missfresh Limited does not pay dividends
What sector is Missfresh Limited in?
Missfresh Limited is in the Consumer Defensive sector
What industry is Missfresh Limited in?
Missfresh Limited is in the Grocery Stores industry
What country is Missfresh Limited based in?
Missfresh Limited is headquartered in China
When did Missfresh Limited go public?
Missfresh Limited's initial public offering (IPO) was on June 25, 2021
Is Missfresh Limited in the S&P 500?
No, Missfresh Limited is not included in the S&P 500 index
Is Missfresh Limited in the NASDAQ 100?
No, Missfresh Limited is not included in the NASDAQ 100 index
Is Missfresh Limited in the Dow Jones?
No, Missfresh Limited is not included in the Dow Jones index
When was Missfresh Limited's last earnings report?
Missfresh Limited's most recent earnings report was on Nov 11, 2021
When does Missfresh Limited report earnings?
The date for Missfresh Limited's next earnings report has not been announced yet